Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer
Baylor College of Medicine · The University of Texas MD Anderson Cancer Center
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
58
total citations
- FWCI
- 36.15
- Percentile
- 100%
- References
- 71
Citations per year
Authors
23Topics & keywords
Topics
Keywords
- Biology
- Arachidonic acid
- Immune system
- Breast cancer
- Triple-negative breast cancer
- Immunology
- Cancer research
- Cancer
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- UDU.S. Department of DefenseAwards: DAMD W81XWH-20-1-0375, DAMD W81XWH-16-1-0073
- BCBreast Cancer Research Foundation
- CPCancer Prevention and Research Institute of TexasAwards: RP200504, P30CA125123, R01CA216426, RP170005, RP180672, CA125123, RR024574, R01CA220297
- DLDan L. Duncan Cancer Center, Baylor College of Medicine
- NINational Institutes of HealthAwards: P30EY002520, S10OD023469, S10OD025240
- NCNational Cancer InstituteAwards: CA183878, CA221946, CA227904, CA253533, DAMD W81XWH-20-1-0375, CA251950, P50CA186784